FINWIRES · TerminalLIVE
FINWIRES

CorMedix's New Major DefenCath Customer Backs 2026 Volumes, Durability Through 2027, RBC Says

By

CorMedix's (CRMD) last major customer for its DefenCath solution could buoy 2026 volumes and back franchise durability in 2027 and beyond, RBC Capital Markets said in a Thursday note.

DefenCath is intended to prevent catheter-related bloodstream infections in patients with end-stage renal disease and the last multi-year contract win with a large dialysis organization in the US indicates continued demand and should boost H2 order volume, RBC said, noting the drug's potential to top $199 million in 2026 revenue.

RBC also noted the company's upcoming supplemental new drug application for Rezzayo, which is currently a treatment of candidemia and invasive candidiasis, as a potential growth driver in 2027. Rezzayo's potential label expansion in prophylaxis could unlock a $200 million market opportunity for CorMedix, the brokerage added.

RBC raised its price target on CorMedix to $14 from $13, with an outperform rating.

Price: $7.75, Change: $-0.39, Percent Change: -4.77%

Related Articles

Wire

Top Cryptocurrencies Mixed; Bitcoin Holds Above $63,000 Level

Major digital assets were mixed on Thursday, with Bitcoin (BTC-USD) holding above the $63,000 level.The CoinDesk Market Index, which tracks dozens of digital assets including Bitcoin, rose 0.1% in the past 24 hours. The Nasdaq 100 rose 1.2%, the S&P 500 added 0.7%, and the Dow Jones Industrial Average increased 0.1%.Bitcoin added 0.2% to $63,361, according to CoinMarketCap data. The most popular cryptocurrency's 24-hour trading volume dropped 13.7% to $19.45 billion.Ethereum (ETH-USD), the second-largest digital asset by market value, rose 0.5% to $1,886.XRP (XRP-USD) added 0.1%, BNB (BNB-USD) eased 0.1%, and Solana (SOL-USD) increased 0.6%. Dogecoin (DOGE-USD) fell 0.4%, while Cardano (ADA-USD) decreased 0.9%.The total market value of the cryptocurrency industry rose 0.1% in the past 24 hours to $2.17 trillion, with trading volume dropping 11.1% to $48.33 billion.Price: $63361.35, Change: $-49.04, Percent Change: -0.08%

$ADA-USD$BNB-USD$BTC-USD$DOGE-USD$ETH-USD$SOL-USD$XRP-USD
Wire

Update: SOLV Energy Shares Rise After Fiscal Q2 Beat

(Updates with the company's latest stock move in the headline and first paragraph.)SOLV Energy (MWH) shares were up over 9% in Thursday trading after the company reported better-than-expected Q2 results and raised its guidance for the full-year.The company posted quarterly net income of $66.8 million, up from $44.6 million a year earlier.Two analysts polled by FactSet expected $41.5 million.Revenue for the quarter ended June 30 was $951.2 million, up from $536.0 million a year earlier.Analysts expected $723.1 million.The company updated its full-year 2026 revenue guidance of about $3.87 billion to $3.97 compared with prior outlook of $3.72 billion to $3.82 billion. Analysts expect $3.79 billion.Price: $32.85, Change: $+2.76, Percent Change: +9.17%

$MWH
Wire

Update: McGraw Hill Shares Rise After Fiscal Q1 Beat

(Updates with the latest stock move in the headline and first paragraph.)McGraw Hill (MH) shares rose more than 16% in afternoon trading on Thursday after the publisher reported better-than-expected fiscal Q1 results.The company posted fiscal Q1 adjusted earnings Thursday of $0.59 per diluted share, compared with a breakeven a year earlier.Analysts polled by FactSet expected non-GAAP EPS of $0.48.Revenue for the quarter ended June 30 was $549.9 million, compared with $535.7 million a year earlier.Analysts expected $532 million.The company reiterated its fiscal 2027 outlook of $2.12 billion to $2.18 billion in revenue. Analysts expect $2.15 billion.Price: $13.47, Change: $+1.87, Percent Change: +16.12%

$MH